Supported Projects
As a neutral and independent organization, the Oncidium foundation is dedicated to expanding global access to radioligand therapy for cancer patients. In line with our mission, we support and engage in strategic projects that are essential to the development, delivery, and sustainability of this innovative treatment approach.
Accelerate.EU
Accelerate.EU is a project pioneering the development of novel radiotheranostic pairs featuring the alpha-emitting isotope astatine-211 (211At) to target aggressive cancers like pancreatic, breast, and brain cancer.
Thera4care
Thera4Care specializes in advanced theranostic solutions, combining expert research with novel technologies to revolutionise healthcare. Our approach enhances precision in both diagnostics and treatments for complex diseases like cancer, utilizing innovative isotopes and imaging techniques to improve patient outcomes.
RLT4BE
RLT4BE is a government-supported initiative bringing together key stakeholders to develop an integrated solution framework and actionable plan to ensure Belgium is future-ready for the implementation and expansion of radioligand therapy (RLT) in cancer treatment.